UNSPSC 51412402: Efloxate

This classification denotes a vasodilating agent with the molecular formula C19H16O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CZU6V3902K, chemically known as acetic acid, ((4-oxo-2-phenyl-4h-1-benzopyran-7-yl)oxy)-, ethyl ester but generally known as efloxate, which bears US NIH Compound Identifier 8395. European Medicines Agency schedules Efloxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06469MIG. The term EFLOXATE is an International Non-Proprietary Name.

UNSPSC 51412402 Efloxate is a Commodity code that covers emergency-response medications procured by state and local public safety agencies. State and local governments buy efloxate and related advanced life support pharmaceuticals — such as labetalol, epinephrine, adenosine, and diltiazem — for use by fire departments, emergency medical services, and other emergency response units. These medications are sourced through sealed-bid procurements in which vendors supply drugs meeting specified potency, expiration-date requirements, and warranty periods. Issuing bodies for this code include city purchasing departments acting on behalf of municipal fire rescue and EMS divisions. Vendors must comply with OSHA Hazard Communication Standards and provide Safety Data Sheets with all shipments; many jurisdictions also require accessibility documentation (VPAT and Section 508 conformance reports) in addition to pharmaceutical compliance.

The City of Tampa Purchasing Department issued a representative recent opportunity in April 2026 (Solicitation 26P00188, closed April 8, 2026) soliciting Advanced Life Support Medications for Tampa Fire Rescue in Hillsborough County, Florida. The IFB requested 370 units of labetalol HCI 100mg vials, 1,810 units of epinephrine 1:10,000 injections, 330 units of adenosine 6mg vials, and 1,020 units of diltiazem 25mg vials, with an estimated contract value of $40,000.00 and a one-year term plus two optional one-year renewals. The solicitation carried a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount (not to exceed $10,000) for SLBE participation. The source reflects limited recent activity under this specific commodity code; the single posted opportunity suggests that emergency-response medication procurement in state and local jurisdictions remains concentrated in a narrow set of buyers and geographies, with Florida representation in the recent record.